- Corporate Officers - P
- Pare Anthony
Insider Trading History of Pare Anthony
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pare Anthony since 2008.
This trader's CIK number is 1418863.
At the time of last reporting, Pare Anthony was the Chief Commercial Officer of T2 Biosystems, Inc.. (stock ticker symbol TTOO).
Also see all insider trading activities at T2 Biosystems, Inc..
Note that in the past
Pare Anthony also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Haemonetics Corp (HAE) by Pare Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | HAE | 231 | $10,245 | 1,000 | $56,690 | 1,000 | $26,104 |
Yearly summary of insider trading at T2 Biosystems, Inc. (TTOO) by Pare Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TTOO | 0 | $0 | 9,620 | $17,700 | 17,500 | $0 |
Insider trading activities at 2 companies by Pare Anthony:
1. Haemonetics Corp (HAE)
2. T2 Biosystems, Inc. (TTOO)
Table 1. Insider trading of Haemonetics Corp (HAE) by Pare Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-06-30 | HAE | Sale | 500 | 57.40 | 28,700 |
| 2008-06-30 | HAE | Option Ex | 500 | 26.11 | 13,052 |
| 2008-05-01 | HAE | Buy | 231 | 44.35 | 10,245 |
| 2008-04-21 | HAE | Sale | 500 | 55.98 | 27,990 |
| 2008-04-21 | HAE | Option Ex | 500 | 26.11 | 13,052 |
Table 2. Insider trading of T2 Biosystems, Inc. (TTOO) by Pare Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-17 | TTOO | Sale | 9,620 | 1.84 | 17,700 |
| 2021-03-14 | TTOO | Option Ex | 17,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pare Anthony
(Chief Commercial Officer of T2 Biosystems, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.